前药
化学
肝星状细胞
纳米医学
药理学
肝纤维化
纤维化
吡非尼酮
活性氧
生物化学
药物输送
细胞生物学
细胞毒性
癌症研究
体内分布
细胞外基质
肝细胞
细胞
核酸
细胞培养
药品
肝功能
体外
靶向给药
作者
Mingming Song,Ying Fang,Xiaqing Gong,Jiandong Wang,Yuan Han,Kai Wang,Xiaowen Yu,Jihui Tang
标识
DOI:10.1186/s12951-026-04878-1
摘要
BACKGROUND: Liver fibrosis represents a critical pathological process in chronic liver disease for which precision therapies remain limited. RESULTS: Here we report a biomimetic nanodrug (RAET NPs) that integrates a reactive oxygen species (ROS)-responsive prodrug of acetate gossypol with hybrid cell membrane camouflage and aptamer-mediated targeting. RAET NPs are constructed through modular assembly: the ROS-responsive prodrug core is encapsulated within a hybrid membrane shell formed by fusing activated hepatic stellate cell (HSC)-derived exosome membranes with M1-type macrophage membranes, followed by decoration with CD44-specific nucleic acid aptamers. This design preserves the full repertoire of membrane-associated targeting proteins while incorporating synthetic aptamers for enhanced recognition specificity. Meanwhile, RAET NPs remain in an inert state under normal physiological conditions to reduce biotoxicity and are converted into active drugs only in the fibrosis-induced reactive oxygen species (ROS)-rich microenvironment, enabling controlled drug release at the lesion site. In both organoid and animal models of liver fibrosis, RAET NPs suppress HSC activation and extracellular matrix deposition, significantly attenuating disease progression. CONCLUSIONS: This biomimetic nanomedicine offers a novel strategy for precision treatment of liver fibrosis through the synergistic function of prodrug and biomimetic delivery.
科研通智能强力驱动
Strongly Powered by AbleSci AI